Side Effects of Trintellix (Vortioxetine)
The most common side effects of Trintellix are nausea, constipation, and vomiting, with nausea being dose-related and typically occurring within the first week of treatment before decreasing in frequency. 1
Most Common Side Effects
- Nausea is the predominant side effect and is dose-dependent, commonly appearing within the first week of treatment, then decreasing in frequency but potentially persisting in some patients 1, 2
- Constipation and vomiting are the other most frequently reported gastrointestinal effects 1
- Additional common side effects include diarrhea, dry mouth, dizziness, and headache 3
- These gastrointestinal and general side effects are consistent with the broader class of second-generation antidepressants 4
Sexual Dysfunction
- Vortioxetine can cause sexual problems in both males and females 1
- In males: delayed ejaculation or inability to ejaculate, problems achieving or maintaining erection, and decreased sex drive 1
- In females: decreased sex drive and delayed or absent orgasm 1
- Patients should be counseled to discuss any changes in sexual function with their provider, as management strategies may be available 1
- Notably, vortioxetine may actually be beneficial for patients who experienced sexual dysfunction on other antidepressants, particularly SSRIs like paroxetine 5
Serious Side Effects Requiring Immediate Attention
Serotonin Syndrome
- A potentially life-threatening condition that requires emergency care 1
- Symptoms include: agitation, hallucinations, confusion, coma, rapid heart rate, blood pressure changes, dizziness, sweating, flushing, hyperthermia, tremors, muscle stiffness or twitching, loss of coordination, seizures, and gastrointestinal symptoms (nausea, vomiting, diarrhea) 1
- Risk increases when combined with other serotonergic medications including triptans, SSRIs, SNRIs, tricyclic antidepressants, lithium, tramadol, fentanyl, other opioids, tryptophan, buspirone, and St. John's Wort 1
Bleeding Risk
- Increased bleeding risk, particularly when combined with aspirin, NSAIDs, warfarin, or other blood thinners 1
- Patients should report any unusual bleeding or bruising immediately 1
Hyponatremia
- Low sodium levels can occur and may be serious or fatal 1
- Elderly patients and those taking diuretics are at higher risk 1
- Symptoms include: headache, difficulty concentrating, memory changes, confusion, weakness, and unsteadiness leading to falls 1
- Severe cases may present with hallucinations, fainting, seizures, coma, or respiratory arrest 1
Angle-Closure Glaucoma
- Vortioxetine can cause mild pupillary dilation, which may trigger angle-closure glaucoma in susceptible individuals 1
- Patients with pre-existing risk factors should consider prophylactic eye examination and treatment (e.g., iridectomy) 1
- Seek immediate care for eye pain, vision changes, or swelling/redness around the eye 1
Psychiatric Side Effects
Activation of Mania/Hypomania
- Manic episodes can occur in patients with bipolar disorder 1
- Warning signs include: greatly increased energy, racing thoughts, grandiose ideas, rapid or excessive talking, severe insomnia, reckless behavior, and excessive happiness or irritability 1
Suicidality
- Increased risk of suicidal thoughts and actions in patients under age 24, especially during the first few months of treatment or with dose changes 1
- Close monitoring is essential for new or sudden changes in mood, behavior, thoughts, or feelings 1
- This risk is consistent with the broader class of SSRIs, which are associated with increased nonfatal suicide attempts (odds ratio 2.25,95% CI 3.3-4.6) 4
Discontinuation Syndrome
- Abruptly stopping Trintellix can cause serious withdrawal symptoms 1
- The dose should be tapered gradually under physician supervision 1
- Discontinuation symptoms include: nausea, sweating, mood changes, irritability, agitation, dizziness, paresthesias (electric shock sensations), tremor, anxiety, confusion, headache, fatigue, insomnia, hypomania, tinnitus, and seizures 1
Pregnancy and Breastfeeding Considerations
- Trintellix may cause neonatal withdrawal symptoms or persistent pulmonary hypertension of the newborn (PPHN) when taken during the third trimester 1
- Pregnant women or those planning pregnancy should discuss risks versus benefits with their provider 1
- A pregnancy registry exists for monitoring outcomes (National Pregnancy Registry for Antidepressants: 1-844-405-6185) 1
- It is unknown whether vortioxetine passes into breast milk 1
Clinical Tolerability Profile
- Vortioxetine is generally well tolerated with side effects typically mild to moderate in severity 5, 2
- In direct comparison to duloxetine, vortioxetine demonstrated lower risk of common antidepressant-induced adverse effects, though with slightly smaller efficacy 3
- The overall safety profile is comparable to existing first-line antidepressants 2
- Nausea and vomiting are the most common reasons for treatment discontinuation in clinical trials 4, 6
Drug Interactions Requiring Caution
- Contraindicated with MAOIs (including linezolid and IV methylene blue) - do not use within 14 days of stopping an MAOI, and wait 21 days after stopping Trintellix before starting an MAOI 1
- Medications requiring careful monitoring include those affecting serotonin, bleeding risk, or metabolized by CYP2D6 1
- Strong CYP2D6 inhibitors (like bupropion) may require dose adjustment 7